Related by context. All words. (Click for frequent words.) 72 multiple myeloma 69 lymphoma 69 non Hodgkin lymphoma 66 chronic lymphocytic leukemia CLL 65 leukemia 65 acute myeloid leukemia 64 Hodgkin lymphoma 63 pancreatic cancer 63 Non Hodgkin Lymphoma 62 lymphatic cancer 62 CLL 62 leukemia AML 61 follicular lymphoma 61 metastatic colon cancer 61 acute leukemia 60 colon cancer 60 cancer 60 cell lymphoma 60 cell lymphoma CTCL 60 indolent NHL 60 gastrointestinal stromal tumors 60 metastatic cancer 60 renal cell carcinoma 59 metastatic melanoma 59 leukemia CLL 59 non Hodgkins lymphoma 59 leukemia ALL 59 Non Hodgkin lymphoma 59 multiple myeloma MM 59 chronic myelogenous leukemia 59 myelodysplastic syndromes 59 lymphoma CTCL 59 amyotrophic lateral sclerosis ALS 59 gastrointestinal stromal tumor GIST 59 solid tumors 59 liver cancer 59 metastatic breast cancer 59 myelodysplastic syndrome MDS 59 carcinoid cancer 59 Glioblastoma Multiforme 59 myelofibrosis 59 hematologic malignancies 58 non Hodgkin Lymphoma 58 prostate cancer 58 bile duct cancer 58 acute myelogenous leukemia AML 58 Hodgkin Lymphoma 58 melanoma 57 glioblastoma 57 acute myeloid leukemia AML 57 Burkitt lymphoma 57 hematological malignancies 57 lymphocytic leukemia 57 bladder cancer 57 systemic lupus erythematosus 57 Multiple Myeloma 57 lung cancer 57 Alzheimer disease 57 myelodysplastic syndrome 57 Acute Myelogenous Leukemia 56 acute promyelocytic leukemia 56 metastatic prostate cancer 56 chronic myeloid leukemia CML 56 chronic myeloid leukemia 56 neuroendocrine cancer 56 indolent lymphoma 56 hematological cancers 56 metastatic renal cell carcinoma 56 Hodgkin lymphoma NHL 56 malignant mesothelioma 56 relapsed leukemia 56 neuroendocrine tumors 56 Hodgkin Disease 56 malignant pleural mesothelioma 56 ovarian cancer 56 lupus nephritis 56 mRCC 56 B CLL 56 relapsing remitting multiple sclerosis 56 Glioblastoma 56 Lymphoma 56 Crohn disease 56 cell lymphomas 56 Non Hodgkin 56 amyotrophic lateral sclerosis 56 gastrointestinal stromal tumor 56 Mantle Cell Lymphoma 56 metastatic colorectal cancer 56 leukemias 55 recurrent NSCLC 55 Follicular lymphoma 55 Non Hodgkins lymphoma 55 cutaneous T cell 55 acute leukemias 55 acute myelogenous leukemia 55 acute lymphoblastic leukemia 55 esophageal cancer 55 pancreatic neuroendocrine tumors 55 sarcoma 55 non Hodgkins Lymphoma 55 PTLD 55 lymphoblastic leukemia 55 Non Hodgkins Lymphoma 55 non hodgkin lymphoma 55 Gleevec imatinib 55 pancreatic adenocarcinoma 55 chronic myelogenous leukemia CML 55 progressive supranuclear palsy 55 lymphomas 55 pancreatic NET 55 Amyotrophic lateral sclerosis ALS 55 HER2 positive breast cancer 55 idiopathic pulmonary fibrosis 55 lymphoblastic lymphoma 55 soft tissue sarcoma 55 myeloproliferative disorders 55 mycosis fungoides 55 Chronic Lymphocytic Leukemia CLL 55 Chronic Lymphocytic Leukemia 55 HER2 positive metastatic breast 55 Rituxan rituximab 55 cell lymphoma ALCL 54 medullary thyroid cancer 54 castration resistant prostate cancer 54 metastatic bladder 54 Hodgkin lymphoma HL 54 ALS 54 Cholangiocarcinoma 54 colorectal cancer 54 relapsed refractory multiple myeloma 54 advanced NSCLC 54 Folotyn 54 Acute Myelogenous Leukemia AML 54 NSCLC 54 cutaneous T 54 metastatic malignant melanoma 54 inoperable pancreatic cancer 54 multiple sclerosis 54 medulloblastoma 54 IV melanoma 54 grade gliomas 54 erlotinib Tarceva 54 small lymphocytic lymphoma 54 gastric cancer 54 Acute Leukemia 54 Lou Gehrig disease 54 idiopathic pulmonary fibrosis IPF 54 refractory acute myeloid 54 refractory multiple myeloma 54 Pancreatic Cancer 54 Gleevec resistant 54 relapsing remitting MS 54 Acute Myeloid Leukemia 54 Acute Lymphoblastic Leukemia 54 myeloproliferative neoplasms 54 malignant melanoma 53 relapsed refractory 53 Burkitt Lymphoma 53 Myelodysplastic Syndrome 53 scleroderma 53 Novartis AG Gleevec 53 Waldenstrom macroglobulinemia 53 differentiated thyroid 53 CTCL 53 prostate cancer mCRPC 53 Advexin 53 thymoma 53 Amrubicin 53 ulcerative colitis 53 Amyotrophic Lateral Sclerosis ALS 53 Zolinza 53 Li Fraumeni Syndrome 53 hormone refractory prostate cancer 53 Gleevec imatinib mesylate 53 Campath alemtuzumab 53 glioblastoma multiforme 53 astrocytoma 53 ALS Amyotrophic Lateral Sclerosis 53 rheumatoid arthritis 53 Chronic lymphocytic leukemia 53 relapsed multiple myeloma 53 Ceflatonin 53 myelodysplastic syndromes MDS 53 neuroblastoma 53 myelofibrosis MF 53 YONDELIS 53 T Cell Lymphoma 53 non Hodgkin lymphomas 53 smoldering myeloma 53 metastatic 53 ankylosing spondylitis 53 Hodgkin disease 53 TREANDA 53 Hepatocellular Carcinoma HCC 53 systemic anaplastic large 53 recurrent ovarian cancer 53 pleural mesothelioma 53 hematological malignancy 53 Sutent 53 Friedreich Ataxia 53 axitinib 52 AA amyloidosis 52 myelodysplasia 52 Chronic Myeloid Leukaemia 52 hematologic disorders 52 tumors GIST 52 Wegener granulomatosis 52 carcinoid tumors 52 non squamous 52 refractory cutaneous T 52 prostate adenocarcinoma 52 nonsmall cell lung cancer 52 Evoltra ® 52 hepatocellular carcinoma 52 DLBCL 52 lupus 52 MALT lymphoma 52 Lou Gerhig disease 52 prostate cancer CRPC 52 Epratuzumab 52 pediatric acute lymphoblastic 52 hepatocellular carcinoma HCC 52 leukaemias 52 mTOR inhibitor 52 fibromyalgia syndrome 52 diagnosed multiple myeloma 52 myeloma 52 Zarnestra 52 recurrent glioblastoma multiforme 52 metastatic malignant 52 Treanda 52 refractory CTCL 52 Alemtuzumab 52 pulmonary arterial hypertension 52 Parkinson disease 52 glioblastoma multiforme GBM 52 tafamidis 52 refractory chronic lymphocytic 52 chronic granulomatous disease 52 abiraterone 52 Ewing sarcoma 52 imatinib resistant 52 brain tumor 52 chronic lymphatic leukemia 52 chemotherapeutic agent 52 Revlimid lenalidomide 52 fungoides 52 follicular lymphoma FL 52 adenoid cystic carcinoma 52 Nexavar sorafenib 52 metastatic pancreatic cancer 52 relapsed ovarian cancer 52 cancers 52 hematological diseases 52 subependymal giant cell 52 Chronic Myelogenous Leukemia CML 52 brain tumor glioblastoma multiforme 52 brain tumors 52 imatinib Gleevec 52 Hodgkins lymphoma 52 diabetic nephropathy 52 azacitidine 51 prostrate cancer 51 metastatic carcinoid 51 Bayer Nexavar 51 polyneuropathy CIDP 51 malignancies 51 nilotinib 51 Duchenne Muscular Dystrophy DMD 51 Fludarabine 51 IV metastatic melanoma 51 Acute Myeloid Leukaemia AML 51 gastrointestinal stromal tumors GIST 51 panitumumab Vectibix 51 myeloid leukemia 51 nasopharyngeal carcinoma 51 systemic scleroderma 51 sorafenib 51 cell lung cancer 51 IV malignant melanoma 51 leukemia APL 51 angiosarcoma 51 Chronic Myeloid Leukemia CML 51 temsirolimus 51 glioblastomas 51 anaplastic astrocytoma 51 acute lymphoblastic 51 inherited neurodegenerative disorder 51 hypereosinophilic syndrome 51 metastatic cancers 51 diffuse intrinsic pontine glioma 51 relapsing remitting 51 romiplostim 51 tyrosine kinase inhibitors TKIs 51 Vidaza azacitidine 51 KRAS mutant 51 metastatic lung cancer 51 metastatic RCC 51 MGUS 51 ADPKD 51 homozygous familial hypercholesterolemia 51 HCV infection 51 Annamycin 51 unresectable 51 Cutaneous T 51 gastrointestinal cancers 51 Crohn Disease 51 CLL SLL 51 Alzheimer disease AD 51 Acute Myeloid Leukemia AML 51 kidney disease 51 frontotemporal dementia 51 Arzerra 51 metastatic renal cell 51 FLT3 51 commercialize deforolimus 51 pulmonary fibrosis 51 cell chronic lymphocytic 51 gefitinib Iressa 51 myelofibrosis polycythemia vera 51 hepatocellular cancer 51 Glioblastoma multiforme GBM 51 non metastatic osteosarcoma 51 HNSCC 51 pediatric malignancies 51 rheumatoid arthritis RA 51 Arzerra ofatumumab 51 refractory Hodgkin lymphoma 51 squamous cell 50 castration resistant 50 histone deacetylase HDAC inhibitor 50 prostate cancer HRPC 50 Velcade bortezomib 50 Ulcerative Colitis 50 Myelofibrosis 50 sarcomas 50 T#I [002] 50 synovial sarcoma 50 recurrent glioblastoma 50 Myelodysplastic Syndromes MDS 50 idiopathic thrombocytopenic purpura ITP 50 squamous cell cancer 50 erlotinib 50 vemurafenib 50 malignant pancreatic 50 cell malignancies 50 Acute myeloid leukemia 50 anticancer therapy 50 cilengitide 50 rituximab 50 cholangiocarcinoma 50 psoriatic arthritis 50 investigational therapies 50 refractory myeloma 50 metastatic disease 50 HER2 positive 50 juvenile myelomonocytic leukemia 50 thalidomide Thalomid 50 taxane chemotherapy 50 Sprycel dasatinib 50 cell carcinoma 50 MYCN amplification 50 CHOP chemotherapy 50 figitumumab 50 Merck KGaA Erbitux 50 metastatic GIST 50 follicular Non Hodgkin 50 Clolar 50 visilizumab 50 Revlimid 50 follicular non 50 Merkel cell carcinoma 50 paclitaxel Taxol ® 50 standard chemotherapy regimen 50 breast cancer 50 gemcitabine chemotherapy 50 cell acute lymphoblastic 50 myelomas 50 non hodgkins lymphoma 50 pancreatic carcinoma 50 refractory indolent non 50 bendamustine 50 carcinoma 50 Romiplostim 50 cystic fibrosis 50 sorafenib Nexavar 50 pemphigus 50 Lou Gherig Disease 50 PCNSL 50 heavily pretreated 50 enzastaurin 50 myelogenous leukemia 50 Chronic Myeloid Leukemia 50 chronic myeloid 50 biliary tract cancer 50 bevacizumab Avastin 50 S. aureus infections 50 heterozygous FH 50 refractory peripheral T 50 hemolytic anemia 50 HuMax CD4 50 Pixantrone 50 paroxysmal nocturnal hemoglobinuria PNH 50 Crohn disease chronic 50 Chronic lymphocytic leukemia CLL 50 dexpramipexole 50 cediranib 50 Ewing Sarcoma 50 metastatic colorectal 50 Amyotrophic lateral sclerosis 50 follicular NHL 50 basiliximab 50 dermatofibrosarcoma protuberans 50 rhabdomyosarcoma 50 Dasatinib 50 tanespimycin 50 Campath 50 Wilm Tumor 50 superficial bladder cancer 50 Idiopathic Pulmonary Fibrosis IPF 50 BAY #-# 50 opioid induced constipation OIC 50 alvespimycin 50 Erlotinib 50 systemic lupus erythematosus SLE 50 leukemias lymphomas 50 Diffuse Large B 50 cetuximab Erbitux 50 colorectal cancer CRC 50 relapsed refractory aggressive 50 angiogenesis inhibition 50 vandetanib 50 imatinib Gleevec ® 50 aplastic anemia 50 BRAF inhibitor 50 Aplidin 50 metastatic kidney 50 TTR amyloidosis 50 JAK inhibitor 50 liver disease 50 sunitinib malate 50 seminoma 50 Bevacizumab 50 pancreatic tumors 50 hepatorenal syndrome 50 Novartis Gleevec 50 neurogenic orthostatic hypotension 50 pazopanib 50 malignant lymphoma 49 previously untreated follicular 49 Bortezomib 49 hemophagocytic lymphohistiocytosis 49 iniparib 49 clofarabine 49 Vandetanib 49 carfilzomib 49 CYT# potent vascular disrupting 49 lymphoma leukemia 49 autoimmune hemolytic anemia 49 minimally symptomatic 49 neuroendocrine cancers 49 Anaplastic 49 Hodgkins Lymphoma 49 tyrosine kinase inhibitors 49 androgen independent 49 psoriasis 49 Troxatyl 49 relapsed MM 49 haematologic malignancies 49 ixabepilone 49 Tarceva erlotinib 49 refractory CLL 49 refractory ovarian cancer 49 Myeloma 49 docetaxel Taxotere R 49 Severe Primary IGFD 49 hypophosphatasia 49 motor neuron disease 49 Rilutek 49 Friedreich ataxia 49 PKCi 49 luteinizing hormone releasing 49 bortezomib 49 fallopian tube carcinoma 49 renal disease 49 dasatinib 49 Alzheimer Disease AD 49 IMGN# 49 pralatrexate 49 soft tissue sarcomas 49 metastatic gastric 49 tumor recurrence 49 sunitinib 49 nonalcoholic steatohepatitis 49 Multiple Myeloma MM 49 mCRC 49 PARP inhibitors 49 Nexavar tablets 49 advanced metastatic renal 49 gastrointestinal stromal tumors GISTs 49 standard chemotherapy regimens 49 myeloproliferative diseases 49 Alzheimers disease 49 multiple sclerosis MS 49 pancreatic islet cell 49 dirucotide 49 familial hypercholesterolemia 49 Avastin bevacizumab 49 Ceflatonin R 49 GIST 49 Arcalyst 49 imatinib mesylate 49 levodopa therapy 49 Krabbe disease 49 Genasense evaluating 49 histologies 49 lateral sclerosis 49 acute myelogenous 49 Myelodysplastic Syndrome MDS 49 relapsing MS 49 Glioblastoma Multiforme GBM 49 relapsed mantle 49 lumiliximab 49 atypical hemolytic uremic syndrome 49 Amyotrophic Lateral Sclerosis 49 ependymoma 49 Gaucher Disease 49 FTY# 49 radiation sensitizer 49 Virulizin ® 49 indolent follicular non 49 infantile spasms IS 49 Fanconi anemia 49 Metastatic breast cancer 49 galiximab 49 brain metastases 49 squamous cell carcinoma SCC 49 lateral sclerosis ALS 49 AVASTIN 49 SJIA 49 nephrotic syndrome 49 chronic HCV 49 Dacogen injection 49 Pompe Disease 49 Hurthle cell 49 Fludara 49 REVLIMID 49 pomalidomide 49 Yervoy 49 glufosfamide 49 Maroteaux Lamy syndrome 49 neurofibromatosis 49 basal cell carcinoma 49 Rituximab 49 Xanafide 49 erlotinib Tarceva ® 49 neurodegenerative disorder 49 hypomethylating agents 49 cell lymphoma PTCL 49 Hodgkin lymphomas 49 infantile spasms 49 malignancy 49 progressive neurodegenerative disorder 49 epithelial tumors 49 interferon therapy 49 paraganglioma 49 GvHD 49 gastric cancers 49 invasive candidiasis 49 FOLOTYN ® 49 related macular degeneration 49 polycythemia vera 49 Duchenne muscular dystrophy 49 thyroid cancer 49 amrubicin 49 interstitial pulmonary fibrosis 49 depsipeptide 49 Sezary syndrome 49 leukemia CML 49 chemotherapy 49 refractory colorectal cancer 49 grade glioma 49 tumors 49 polycythemia vera PV 49 tyrosine kinase inhibitor 49 Vectibix 49 colon lung 49 humanised monoclonal antibody 49 MELAS 49 Omacetaxine 49 IgG1 monoclonal antibody 49 Revimmune 48 stage IIIB 48 mutated KRAS 48 Kaposi sarcoma 48 Parkinson disease PD 48 autoimmune disease 48 Leukine 48 pancreatic tumor 48 non alcoholic steatohepatitis 48 anaplastic 48 TEMODAL 48 dasatinib Sprycel 48 SHPT 48 APOPTONE 48 Evoltra TM 48 relapsed acute lymphoblastic 48 refractory AML 48 Kit CD# positive 48 anthracycline taxane 48 Torisel 48 relapsed SCLC 48 Pathway Inhibitor 48 diabetic kidney 48 INCB# [003] 48 efalizumab 48 mycophenolate mofetil 48 sunitinib Sutent 48 hematopoietic malignancies 48 papillary renal cell carcinoma 48 anti CD3 antibody 48 RRMS 48 Waldenstrom Macroglobulinemia 48 essential thrombocythemia 48 acute promyelocytic leukemia APL 48 Atiprimod 48 refractory chronic myeloid 48 cetuximab 48 onset Alzheimer 48 Alimta pemetrexed 48 Idiopathic Thrombocytopenic Purpura ITP 48 chronic plaque psoriasis 48 HER2 overexpression 48 L BLP# 48 EGFR inhibitors 48 Crizotinib 48 castrate resistant prostate cancer 48 anal cancer 48 Non Hodgkin Lymphomas 48 Cytoxan 48 palliative radiotherapy 48 neurodegenerative disease 48 leukemia lymphoma multiple myeloma 48 Acute Lymphocytic Leukemia 48 immune thrombocytopenic purpura ITP 48 pemphigus vulgaris 48 Gorlin syndrome 48 neuro endocrine tumors 48 abiraterone acetate 48 refractory APL 48 relapsed CLL 48 Everolimus 48 romidepsin 48 Herceptin trastuzumab 48 acute lymphocytic leukemia 48 pemetrexed Alimta 48 K RAS 48 forodesine 48 immunological diseases 48 Azedra 48 Philadelphia Chromosome Positive 48 metastatic castration resistant 48 kidney urologic 48 Huntington Disease 48 Cabazitaxel 48 IV NSCLC 48 familial ALS 48 Etanercept 48 Erbitux cetuximab 48 bladder cancers 48 Cinquil 48 GRN#L 48 chlorambucil 48 proteasome inhibitor 48 Hashimoto thyroiditis 48 dirucotide MBP# 48 prostate cancers 48 advanced carcinoid 48 receptor tyrosine kinase inhibitor 48 Carcinoid tumors 48 metastatic ovarian cancer 48 Pompe disease 48 bone metastases 48 Pralatrexate 48 Leber Congenital Amaurosis LCA 48 hereditary angioedema 48 myeloma cells 48 alcoholic hepatitis 48 rheumatoid arthritis Crohn disease 48 Atacicept 48 chorea associated 48 Alessandro Riva 48 monoclonal antibody therapies 48 Canvaxin 48 medulloblastomas 48 operable breast cancer 48 refractory gout 48 metastatic carcinoma 48 diffuse gastric 48 alkylating agent 48 lobular carcinoma 48 homozygous FH 48 Duchenne Muscular Dystrophy 48 haematological cancers 48 Arranon 48 primary immunodeficiency PI 48 tumor 48 demethylating agents 48 platinum refractory 48 Myelodysplastic syndrome 48 severe sepsis 48 thymic carcinoma 48 neuronal ceroid lipofuscinosis NCL 48 Metastatic melanoma 48 immune thrombocytopenic purpura 48 Spinal Muscular Atrophy 48 prostate pancreatic 48 Shark cartilage 48 Lou Gehrig Disease 48 Plicera 48 vinorelbine 48 systemic ALCL 48 COPREXA 48 dacetuzumab 48 cetuximab Erbitux R 48 Aflibercept 48 Rituxan 48 docetaxel chemotherapy 48 SUTENT ® 48 Humira adalimumab 48 myotonic muscular dystrophy 48 demonstrated antitumor activity 48 Follicular Lymphoma 48 dasatinib Sprycel ® 48 Xcytrin 48 lymphoproliferative disorders 48 ofatumumab 48 bone metastasis 48 AAT deficiency 48 sargramostim 48 Sorafenib 48 refractory HL 48 esophagitis 48 Gleevec Glivec 48 untreated chronic lymphocytic 48 serous ovarian cancer 48 Rhabdomyosarcoma 48 Adenoid Cystic Carcinoma 48 AML Leukemia 48 refractory Hodgkin 48 Navelbine ® 48 esophageal adenocarcinoma 48 embryonal rhabdomyosarcoma 48 hereditary angioedema HAE 48 malignant tumors 48 prostate tumor 48 chronic ITP 48 Crohn 48 mastocytosis 48 lung tumors 48 acute myeloid 48 AP# [003] 48 Hycamtin 48 prostate cancer AIPC 48 precursor acute lymphoblastic 48 amyloidosis 48 chronic eosinophilic leukemia 48 prostate cancer CaP 48 Clofarabine 48 Leukemias 48 cutaneous melanoma 48 drug figitumumab 48 ankylosing spondylitis AS 48 pulmonary hypertension 48 Dacogen 48 active ankylosing spondylitis 48 Jevtana 48 Ontak 48 stem cell transplant 48 Velcade 48 Mitoxantrone 48 APOL1 48 Leukemia 48 cell lymphoma DLBCL 48 colorectal cancer liver metastases 48 basal cell nevus syndrome 48 macroglobulinemia 47 zanolimumab 47 oligodendrogliomas 47 osteosarcoma 47 Aviptadil 47 T#I mutant 47 advanced epithelial ovarian 47 OMAPRO 47 Riluzole 47 rheumatoid arthritis psoriatic arthritis 47 Genasense ® 47 TACI Ig 47 cervical carcinoma 47 chemotherapy regimens 47 trabectedin 47 doxorubicin HCl liposome injection 47 chemotherapy regimen 47 temozolomide 47 trastuzumab Herceptin 47 measurable tumor regressions 47 anaplastic thyroid cancer 47 myasthenia gravis 47 carcinoid 47 smoldering multiple myeloma 47 treating chronic myeloid 47 familial pancreatic cancer 47 aHUS 47 Lou Gherig disease 47 Axitinib 47 VIDAZA 47 ATTR PN 47 CLL cells 47 transthyretin amyloidosis 47 OncoVEX GM CSF 47 cetuximab Erbitux ® 47 hormone refractory metastatic prostate 47 Alzheimer 47 Amigal 47 Lou Gehrigs disease 47 pulmonary arterial hypertension PAH 47 vinca alkaloid 47 Maroteaux Lamy Syndrome 47 imatinib 47 Genentech Rituxan 47 Wilms tumor 47 ASA# 47 juvenile idiopathic arthritis JIA 47 Revlimid pill 47 Tasigna nilotinib 47 Theratope 47 Degarelix 47 allogeneic bone marrow 47 Perifosine 47 relapsed 47 Idiopathic Pulmonary Fibrosis 47 cladribine 47 basal cell carcinoma BCC 47 dyskeratosis congenita 47 idiopathic thrombocytopenic purpura 47 proliferative disorders 47 Parkinson Disease 47 endometrial cancer 47 malignant pheochromocytoma 47 baminercept 47 chronic HCV infection 47 ovarian breast 47 Lewy Body dementia 47 untreated metastatic pancreatic 47 Diffuse Intrinsic Pontine Glioma 47 Cell Lymphoma 47 degenerative disorder 47 BRAF V# mutation 47 iron overload 47 Hurler syndrome 47 chronic ITP patients 47 Wiskott Aldrich Syndrome 47 anemias 47 resistant ovarian cancer 47 ZACTIMA TM ZD# 47 acute leukemia AML 47 congestive heart failure 47 K ras mutations 47 NovoTTF 47 cabazitaxel 47 von Willebrand disease 47 p# biomarker 47 Halaven 47 multi kinase inhibitor 47 ADI PEG 47 Krabbe Disease 47 INCB# [001] 47 MGd 47 Cariprazine 47 debilitating autoimmune 47 lung fibrosis 47 cytokine refractory 47 cancer cachexia 47 ipilimumab 47 epithelial cancers 47 radioimmunotherapy 47 proteasome inhibitors 47 Hodgkins Disease 47 chronic kidney 47 hepatoblastoma 47 liver fibrosis 47 pontine glioma 47 PRTX 47 recurrent colorectal cancer 47 anti angiogenic therapy 47 Tarceva TM 47 gastrin analogue TT 47 Multiple Sclerosis 47 familial amyloidotic polyneuropathy FAP 47 sclerosis ALS 47 mesothelioma 47 paclitaxel Taxol R 47 relapsed GBM 47 stage IIIA 47 EGFr 47 malignant gliomas 47 refractory SCLC 47 cirrhosis liver failure 47 lysosomal storage disease 47 EGFR expressing 47 leiomyosarcoma 47 Ilaris 47 FSGS 47 PI3K/Akt pathway inhibitor 47 Osteosarcoma 47 Pemetrexed 47 chronic idiopathic thrombocytopenic purpura 47 advanced hepatocellular carcinoma 47 autoantibody positive 47 diffuse pontine glioma 47 Chronic Myelogenous Leukemia 47 colorectal carcinoma 47 Cremophor 47 squamous 47 ADVEXIN 47 hormone deprivation 47 Huntingtons disease 47 Glioma 47 endocrine therapies 47 gastrointestinal GI cancers 47 alveolar rhabdomyosarcoma 47 relapsing multiple sclerosis 47 refractory NSCLC 47 liver metastases 47 anthracyclines 47 vasculitis 47 AMN# [001] 47 squamous cell lung cancer 47 PXD# 47 colorectal liver metastases 47 Burkitts Lymphoma 47 Certolizumab pegol 47 anticancer therapies 47 Vasculitis 47 davunetide 47 postherpetic neuralgia 47 Ofatumumab 47 Duchenne muscular dystrophy DMD 47 Nuvion 47 SSc 47 Enzastaurin 47 samalizumab 47 Taxotere docetaxel 47 relapsed Acute Myeloid 47 cell carcinoma RCC 47 alefacept 47 sorafenib tablets 47 Golimumab 47 papillary thyroid cancer 47 pouchitis 47 trastuzumab Herceptin ® 47 TNF antagonist 47 Decitabine 47 Phenoptin 47 docetaxel Taxotere 47 breast carcinomas 47 perifosine 47 inflammatory bowel disease 47 Sutent sunitinib 47 Cryopyrin Associated Periodic Syndromes 47 Sudhir Agrawal D.Phil 47 grade cervical intraepithelial 47 Nephrotic Syndrome 47 MPS VI 47 node metastases 47 GED aPC 47 rheumatoid arthritis juvenile idiopathic 47 hypoparathyroidism 47 eltrombopag 47 frontotemporal dementia FTD 47 pediatric bipolar disorder 47 acute GvHD 47 psoriasis rheumatoid arthritis 47 EGFR tyrosine kinase inhibitors 47 BRAF mutation 47 Acute lymphoblastic leukemia 47 Von Willebrand disease 47 MDV# 47 hematological disorders 47 prostate cancer PCa 47 Nilotinib 47 refractory lymphoma 47 voreloxin 47 Neuvenge 47 OHR/AVR# 47 nonmelanoma skin cancers 47 colon carcinoma 47 muscular dystrophy 47 pertuzumab